The global cannabis testing market is expected to reach USD 1,416.3 Million by 2021 from USD 822.0 Million in 2016, at a CAGR of 11.5% during the forecast period .
Download FREE Brochure @ https://www.marketsandmarkets.com/pdfdownload.asp?id=46932450
The growth in this market is mainly driven by factors such as legalization of medical cannabis, coupled with the growing number of cannabis testing laboratories (specifically in the U.S.); growing adoption of LIMS in cannabis testing laboratories; and increasing awareness through conferences, symposia, and workshops.
On the other hand, the high cost of analytical instruments, presence of alternative technologies, and dearth of skilled professionals are some of the major factors that are expected to restrain the growth of this market in the coming years.
This report segments the cannabis testing market into cannabis testing products (analytical instruments and consumables) & software (Cannabis LIMS), cannabis testing services, end users, and regions.
On the basis of products, the market is broadly categorized into two segments, namely, analytical instruments and consumables. The consumables segment is expected to grow at the highest CAGR during the forecast period owing to their recurring requirement and repetitive usage.
The cannabis testing services market (services offered by cannabis testing laboratories) is segmented into potency testing, terpene profiling, pesticide screening, residual solvent screening, heavy metal testing, microbial analysis, and genetic testing. The potency testing segment accounted for the largest share in 2016 and also expected to grow at the highest CAGR during the forecast period as a majority of the end users primarily test their cannabis plants for cannabinoids and look for evaluating the strength of cannabis and the effect it will have on medical marijuana users.
On the basis of end user, the cannabis testing products & software market is further segmented into laboratories and research institutes. Laboratories are expected to register the highest CAGR during the forecast period. The high share of this segment is attributed to the increasing demand for cannabis testing products and software among labs. This is particularly evident in the U.S., where the number of cannabis testing laboratories has grown due to the legalization of the use of cannabis in medicine, increasing expansion of leading cannabis testing laboratories, and growing availability of technologically advanced analytical instruments and software (LIMS) for the cannabis industry.
On the basis of end user, the cannabis testing services market is further segmented into cannabis testing drug manufacturers & dispensaries and cannabis cultivators. In 2016, cannabis drug manufacturers & dispensaries accounted for the largest share of the cannabis testing services market. The growth of this market segment is mainly driven by regulatory guidelines mandating cannabis testing.
